Susquehanna International Group, LLP Pro Phase Labs, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 46,951 shares of PRPH stock, worth $15,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,951

Previous 64,906 27.66%

Holding current value

$15,963

Previous $157,000 77.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.61 - $2.47 $10,952 - $44,348	-17,955 Reduced 27.66%	46,951 $35,000
Q3 2024 Nov 14, 2024	BUY	$2.16 - $4.06 $5,244 - $9,857	2,428 Added 3.89%	64,906 $157,000
Q2 2024 Aug 15, 2024	BUY	$4.18 - $7.35 $32,729 - $57,550	7,830 Added 14.33%	62,478 $261,000
Q1 2024 May 07, 2024	BUY	$4.47 - $6.47 $244,276 - $353,572	54,648 New	54,648 $353,000
Q2 2023 Aug 11, 2023	SELL	$7.15 - $9.78 $194,851 - $266,524	-27,252 Reduced 71.22%	11,014 $79,000
Q1 2023 May 16, 2023	SELL	$6.62 - $9.57 $53,112 - $76,780	-8,023 Reduced 17.33%	38,266 $291,000
Q4 2022 Feb 14, 2023	BUY	$8.78 - $12.47 $406,417 - $577,223	46,289 New	46,289 $445,000
Q1 2022 May 16, 2022	SELL	$6.2 - $7.87 $124,328 - $157,817	-20,053 Reduced 63.69%	11,434 $80,000
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.82 $184,817 - $295,556	-37,795 Reduced 54.55%	31,487 $164,000
Q2 2021 Aug 11, 2021	BUY	$4.61 - $6.83 $166,195 - $246,228	36,051 Added 108.49%	69,282 $430,000
Q1 2021 May 17, 2021	BUY	$6.19 - $16.0 $205,699 - $531,696	33,231 New	33,231 $246,000
Q3 2020 Nov 16, 2020	SELL	$1.4 - $3.87 $26,509 - $73,278	-18,935 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.2 - $1.99 $12,938 - $21,456	-10,782 Reduced 36.28%	18,935 $28,000
Q1 2020 May 15, 2020	BUY	$1.74 - $2.1 $15,534 - $18,748	8,928 Added 42.95%	29,717 $56,000
Q4 2019 Feb 14, 2020	SELL	$1.66 - $2.2 $3,990 - $5,288	-2,404 Reduced 10.37%	20,789 $41,000
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.2 $15,445 - $20,847	9,476 Added 69.08%	23,193 $42,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.07 $28,805 - $42,111	13,717 New	13,717 $29,000
Q4 2018 Feb 14, 2019	SELL	$2.95 - $3.27 $29,733 - $32,958	-10,079 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.94 - $3.23 $29,632 - $32,555	10,079 New	10,079 $30,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

2.35M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $5.45M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pro Phase Labs, Inc. Transaction History